Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2)

被引:1252
作者
Revy, P
Muto, T
Levy, Y
Geissmann, F
Plebani, A
Sanal, O
Catalan, N
Forveille, M
Dufourcq-Lagelouse, R
Gennery, A
Tezcan, I
Ersoy, F
Kayserili, H
Ugazio, AG
Brousse, N
Muramatsu, M
Notarangelo, LD
Kinoshita, K
Honjo, T
Fischer, A
Durandy, A [1 ]
机构
[1] Hop Necker Enfants Malad, INSERM, U429, Paris, France
[2] Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto, Japan
[3] Hop Cochin, INSERM, U474, F-75674 Paris, France
[4] Hop Necker Enfants Malad, Serv Anatomopathol, Paris, France
[5] Univ Brescia, Pediat Clin, Brescia, Italy
[6] Univ Brescia, Ist Med Mol Angelo Novicelli, Brescia, Italy
[7] Hacettepe Univ, Div Immunol, Ihsan Dogramaci Childrens Hosp, Ankara, Turkey
[8] Istanbul Univ, Inst Child Hlth, Istanbul, Turkey
[9] Hop Necker Enfants Malad, Unite Immunol Hematol, Paris, France
关键词
D O I
10.1016/S0092-8674(00)00079-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The activation-induced cytidine deaminase (AID) gene, specifically expressed in germinal center B cells in mice, is a member of the cytidine deaminase family. We herein report mutations in the human counterpart of AID in patients with the autosomal recessive form of hyper-IgM syndrome (HIGM2). Three major abnormalities characterize AID deficiency: (1) the absence of immunoglobulin class switch recombination, (2) the lack of immunoglobulin somatic hypermutations, and (3) lymph node hyperplasia caused by the presence of giant germinal centers. The phenotype observed in HIGM2 patients (and in AID(-/-) mice) demonstrates the absolute requirement for AID in several crucial steps of B cell terminal differentiation necessary for efficient antibody responses.
引用
收藏
页码:565 / 575
页数:11
相关论文
共 77 条
  • [11] ACTIVATION OF HUMAN B-CELLS MEDIATED THROUGH 2 DISTINCT CELL-SURFACE DIFFERENTIATION ANTIGENS, BP35 AND BP50
    CLARK, EA
    LEDBETTER, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) : 4494 - 4498
  • [12] HYPER IGM SYNDROME-ASSOCIATED WITH DEFECTIVE CD40-MEDIATED B-CELL ACTIVATION
    CONLEY, ME
    LARCHE, M
    BONAGURA, VR
    LAWTON, AR
    BUCKLEY, RH
    FU, SM
    COUSTANSMITH, E
    HERROD, HG
    CAMPANA, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (04) : 1404 - 1409
  • [13] IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES)
    CORDELL, JL
    FALINI, B
    ERBER, WN
    GHOSH, AK
    ABDULAZIZ, Z
    MACDONALD, S
    PULFORD, KAF
    STEIN, H
    MASON, DY
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) : 219 - 229
  • [14] COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252
  • [15] RNA:DNA complex formation upon transcription of immunoglobulin switch regions: Implications for the mechanism and regulation of class switch recombination
    Daniels, GA
    Lieber, MR
    [J]. NUCLEIC ACIDS RESEARCH, 1995, 23 (24) : 5006 - 5011
  • [16] CD40 LIGAND MUTATIONS IN X-LINKED IMMUNODEFICIENCY WITH HYPER-IGM
    DISANTO, JP
    BONNEFOY, JY
    GAUCHAT, JF
    FISCHER, A
    DESAINTBASILE, G
    [J]. NATURE, 1993, 361 (6412) : 541 - 543
  • [17] DNA polymerase mu (Pol μ), homologous to TdT, could act as a DNA mutator in eukaryotic cells
    Domínguez, O
    Ruiz, JF
    de Lera, TL
    García-Díaz, M
    González, MA
    Kirchhoff, T
    Martínez-A, C
    Bernad, A
    Blanco, L
    [J]. EMBO JOURNAL, 2000, 19 (07) : 1731 - 1742
  • [18] INDUCTION BY ANTI-CD40 ANTIBODY OR SOLUBLE CD40 LIGAND AND CYTOKINES OF IGG, IGA AND IGE PRODUCTION BY B-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME
    DURANDY, A
    SCHIFF, C
    BONNEFOY, JY
    FORVEILLE, M
    ROUSSET, F
    MAZZEI, G
    MILILI, M
    FISCHER, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) : 2294 - 2299
  • [19] Durandy A, 1997, J IMMUNOL, V158, P2576
  • [20] DURANDY A, 1990, J IMMUNOL, V144, P60